China's leading manufacturer of optical products addresses increasing demand for high-quality wide-angle imagery and advanced applications in consumer, industrial, and professional markets including mobile, automotive, and AI. MONTREAL -Thursday, December 14th 2017 [ AETOS Wire ] (BUSINESS WIRE)-- ImmerVision, developer of exclusive and patented panomorph wide-angle imaging technology, is proud to announce that Sunny Optics (Zhongshan) Co., a subsidiary of Sunny Optical Technology (Group) Co. Ltd., a leading manufacturer of integrated optical components and products, has licensed panomorph lens technology for global production, and will deliver its first small form-factor panomorph high-resolution super-wide-angle lenses for smartphones and mobile devices in Q1 2018. Panomorph lens technology combines state-of-the-art optical design and advanced, optimized algorithms, including low-power dewarping, to produce high-resolution super-wide-angle images without distortion, even in low ... Read more »

Ibn Bey: « La Maison de la Famille Egyptienne » est un modèle d'unité nationale et de coexistence Ibn Bey: Le prix est inspiré par l'héritage de la paix dans l'Islam, mais la majorité l’ignore Abu Dhabi, Émirats Arabes Unis-Mardi 19 Décembre 2017 [ AETOS Wire ] Son Altesse Abdullah bin Zayed Al Nahyan, Ministre des Affaires Etrangères et de la Coopération Internationale, Son Altesse Cheikh Nahyan bin Mubarak Al Nahyan, Ministre de la Tolérance, Son Excellence Cheikh Abdullah Bin Bey, président du «Forum pour la Promotion de la Paix dans les Sociétés Musulmanes, ont honoré le lauréat du « Prix International pour la Paix de Hassan bin Ali - édition 2017, pour la catégorie « la Maison de la Famille Egyptienne », représenté par Dr Mahmoud Hamdi Zaqzouq, Secrétaire Général de la Maison, et l'évêque Jérémie Sous-Secrétaire Général de la Maison. S’exprimant lors de la cérémonie de remise des prix assistée par une grande foule de scientifiques, intellectuels et représentants des religions ... Read more »

RAK pharmaceutical company was platinum sponsor of event Showcased new erectile dysfunction product Ras Al Khaimah, United Arab Emirates -Monday, December 18th 2017 [ AETOS Wire ] Julphar (Gulf Pharmaceutical Industries), the largest generic pharmaceutical manufacturer in the MENA region, marked its entry into the men’s health sector with the launch of a new erectile dysfunction product, Dandasha (Tadalafil 20 mg), at the first Men’s Health Congress. Julphar participated as platinum sponsor of the event, a leading platform dedicated to addressing men’s health issues. It was organized under the patronage of His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance and the President of the Dubai Health Authority and was held at the Mohammed bin Rashid Academic Medical Center, Dubai Healthcare City. The RAK-based pharmaceutical company later hosted an event to showcase Dandasha at the One&Only Royal Mirage Dubai, which was attended by His High ... Read more »

GREENWICH, Conn. -Friday, December 15th 2017 [ AETOS Wire ] (BUSINESS WIRE)-- Interactive Brokers Group, Inc. (NASDAQ GS: IBKR), a global electronic brokerage firm, will now accept orders for short sales of Cboe Futures Exchange (CFE) Bitcoin futures that began trading on the IBKR platform on Sunday, December 10, 2017. Interactive Brokers requires margin of $40,000 per contract for short sales in CFE Bitcoin futures. Margin on long positions of CFE Bitcoin futures is currently $9,000. “The introduction of short sales was necessitated by the large premium of the January futures contract over the price at which Bitcoin trades on the physical venues,” said Interactive Brokers founder, Chairman and CEO Thomas Peterffy. Interactive Brokers requires customers who wish to trade Bitcoin futures to execute a special agreement acknowledging the risk inherent in the contract. Current and new clients can learn more about trading Bitcoin futures with IBKR and sign up for “Crypto” trading permiss ... Read more »

– Data will be Featured in the Plenary Scientific Session on December 10, 2017 with Simultaneous Publication in the New England Journal of Medicine – – Randomized Phase 3 Clinical Trial with ADCETRIS Met Primary Endpoint, Demonstrating a Statistically Significant Improvement in Modified Progression-Free Survival – CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash.-Thursday, December 14th 2017 [ AETOS Wire ] (BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ECHELON-1 clinical trial evaluating ADCETRIS (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in untreated advanced classical Hodgkin lymphoma will be presented in the Plenary Scientific Session at the 59th American Society of Hematology (ASH) annual meeting on Sunday, December 10, 2017. The data were also simultaneously published online in the New England Journal of Medicine and will be published in t ... Read more »